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March through September 2003, patients and their caregiver were
asked to complete surveys to evaluate the video. Likert scales were
used to evaluate the usefulness of the presentation, transplant
information required by the patient to make a decision, appropri-
ateness of the information, the length of the presentation, and the
usefulness of the corresponding handout. Eighty-ﬁve patient and
121caregiver surveys were returned. Overall, patients rated the
usefulness of the presentation from useful to very useful. Our
detailed ﬁndings will be reported. As a result of this media the
education for the patient and family has become more consistent
and detailed. The video on-demand service can be easily updated
for staff changes or future developments in BMSCT.
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A PILOT TEST OF AN APN INTERVENTION IN HCT PATIENTS
Cooke, L.D., Grant, M.M. City of Hope Medical Center, Duarte, CA
Purpose/Specific Aims: The purpose of this project was to pilot
test and reﬁne an advanced practice nurse (APN) multidimensional
intervention on quality of life (QOL) for hematopoetic cell trans-
plant (HCT) patients. Conceptual Framework: This study is
based on the City of Hope (COH) QOL Conceptual Model which
depicts four domains: physical, psychological, social and spiritual
well-being. Methods: The independent variable for this study is
the APN intervention which consisted of teaching sessions at 4
time periods: discharge, and 3 weekly additional teaching sessions.
Dependent variables: QOL, sexuality, fatigue, readmission patterns
and patient satisfaction with the intervention. Design was a 6
month longitudinal design. A sequential sample of 10 allogeneic
patients was obtained from one site. The study collected patient
data at 3 intervals: discharge, 3-5 weeks post discharge, and 6
months. Tools used were COH Bone Marrow Transplant Tool
QOL Tool, POMS (Short Version Fatigue Subscale), GSSI, De-
mographic, Treatment and Readmission tool, Debrieﬁng Form,
Satisfaction Tool. Findings: All patients were allogeneic transplant
recipients, 2 males and 8 females. No deaths within 6 months of
transplant. 50% of the patients were not readmitted. While overall
QOL scores showed slight improvement by 6 months, social well-
being subscale scores decreased. Fatigue scores indicated moderate
fatigue at discharge with a slight improvement at 6 months. Sexual
activity increased from post discharge to 6 months. Mean program
satisfaction score was excellent (1.3) with a scale of 1-5 (1  very
satisﬁed, 5  very dissatisﬁed). Implications for Practice: This
study provided valuable data on the transplant population of an
APN intervention during the critical 3-6 month period post trans-
plant. QOL scores indicated improvement after the invention and
suggest an extended intervention may be more beneﬁcial. Low
social well-being scores highlight the need for possible family
interventions. This study laid groundwork for planning of a larger
study.
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AN INVESTIGATIONAL STUDY ON TELEPHONE CALLS BY PERIOD POST
STEM CELL TRANSPLANTATION
Kim, K.S., Choi, S.E., Bok, J.N., Song, B.E. Cathloic HSCT Center
St.Mary’s Hospital The Catholic University, Seoul, Korea
Stem cell transplantation is a procedure used for the treatment of
hematological malignancy and offers potential long-term survival.
Although the patients were overwhelmingly positive and support
they had received about the information, an important number of
them felt inadequately prepared for the psychosocial problems they
had to face in the ﬁrst period after discharge. The purpose of this
study was to investigate the current status of the question by
telephone post stem cell transplantation at home.
Coordinator of the BMT center wrote down the telephone
record of calls by patients or caregivers post stem cell transplan-
tation from May to September, 2003.
Records of 212 patients with hematological malignance, who
stem cell transplanted between 1999 and 2003, were reviewed.
Content of 212 telephone calls were analyzed into frequency of
general characteristics and needs. The needs at the stage of post
stem cell transplantation were analyzed using SAS program for 2
test.
The content of telephone call was classiﬁed into ﬁve categories.
These included (1) nutrition and diet(48.58%), (2) physical symp-
toms(29.25%), (3) medication and vaccination(11.33%), (4) gen-
eral life style(7.08%), (5) others(3.76%).
The most frequent telephone calls were nutrition and diet (2 
42.972, p  0.001) within 1 year.
The most needs of symptom were pain. After 1 year, they have
started needs of general life style and gynecologic problem.
The results of this study will be useful as an effective reference
for patients and their caregivers by period after stem cell trans-
plantation. The results will be used as reliable data for expansion of
nursing service in the health care delivery system as well as for the
development of telephone intervention service program in our
country.
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EVALUATING THE QUALITY OF BLOOD AND MARROW TRANSPLANTA-
TION (BMT) NURSING CARE WITH A PATIENT PERCEPTION INSTRU-
MENT
La Coste, C.M., Blackburn, R., Johnston, P., Neumann, J. The Uni-
versity of Texas M.D. Anderson Cancer Center, Houston, TX
Evaluating the quality of nursing care on a BMT unit can be
difﬁcult and frequently does not include the consumer of that
activity, the patient. Likewise, post-discharge patient satisfaction
surveys usually afford little information about what the patient
thought about their nursing care. The BMT Department of our
center identiﬁed the need to evaluate the quality of nursing care on
our inpatient unit. The unit-based research council coordinated
with the quality improvement council to develop and implement a
project to evaluate the BMT patients’ perception of nursing care
on our inpatient unit. The stated project objectives include assess-
ing the patients’ willingness and ability to complete the forms,
evaluating the nursing staff’s willingness to approach patients
about the project, identify the strengths and weaknesses on nursing
care on our unit, and evaluating how patient-centered our care is
perceived to be.
The council members sought out an established and accepted
patient satisfaction tool. After an extensive search, the 19 item
Oncology Patients’ Perceptions of the Quality of Nursing Care Scale
(OPPQNCS) was thought to be the most relevant with previously
demonstrated acceptable reliability and validity for oncology pa-
tients. Permission has been obtained from the author, Dr. Laurel
Radwin, and this study will begin to accrue patients in September
of 2003 with a target number of one hundred patients. Surveys will
be distributed at patient discharge classes, which patients attend
approximately one week prior to discharge. Locked return boxes
Table. The Contents of Telephone Call Interview by Period Post–
Stem Cell Transplantation
<3
Months
4-6
Months
7-12
Months
13-24
Months
>25
Months Total 2 (p)
N (%) N (%) N (%) N (%) N (%) N (%)
42.972
(0.001)
Nutrition
and diet
26
(13.68)
34
(16.04)
27
(12.74)
13
(6.13)
0
(0.00)
103
(48.58)
Physical
symptoms
11
(5.19)
11
(5.19)
19
(8.96)
17
(8.02)
4
(1.89)
62
(29.25)
Medication
and
vaccination
4
(1.89)
5
(2.36)
10
(4.72)
4
(1.89)
1
(0.47)
24
(11.33)
General
life style
5
(2.36)
2
(0.94)
3
(1.42)
1
(0.47)
4
(1.89)
15
(7.08)
Others
0
(0.00)
2
(0.94)
2
(0.94)
2
(0.94)
2
(0.94)
8
(3.76)
Total
49
(23.12)
54
(25.47)
61
(28.77)
37
(17.45)
11
(5.19)
212
(100.00)
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will be located in patient accessible areas around the unit to ensure
anonymity. Based upon admission rates, it is anticipated that data
collection will be complete by December. Descriptive statistics will
be used to evaluate items on the OPPQNCS, return rates will be
calculated, and staff will be polled as to any difﬁculty approaching
patients.
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MULTIDISCIPLINARY CLINICAL INITIATIVES TO DECREASE THE RISK
OF ETHICAL DILEMMAS
Neumann, J.L., Trevino, C., Hosing, C., Champlin, R. The University
of Texas MD Anderson Cancer Center, Houston, TX
Blood and Marrow Transplantation (BMT) healthcare providers
are confronted by a number of clinical situations that may chal-
lenge their technical skills, intellect, as well as beliefs, values and
principles. Having a professional responsibility to advocate for
patients, practitioners may have to come to terms with competing
ethical principles presented by differences in resources allocation,
religious beliefs, and societal mores. BMT care is unique in that
patients present with a life threatening illness, if untreated. In
addition, many of the interventions for control or cure tend to be
very aggressive and can greatly impact the individual’s quality of
life. The uncertainty related to the treatment options and out-
comes may also lead to difﬁculty in decisions making and potential
ethical dilemmas.
The purpose of this poster or presentation will be to identify
clinical initiatives, which have been successful in preventing or
resolving ethical dilemmas challenging the patient/family and the
healthcare team. These ethical issues include: advanced level of
appropriate care; informed consent; do not resusciate; and discon-
tinuation of medically inappropriate care. Clinical initiatives that
are currently being utilized include: ethics rounds; informal ethics
consult; advanced directive taskforce; care conferences; self-care
and caregiver agreements; and creation of a compliance algorithm/
pathway. Results of nurse survey examining the impact of ethics
rounds will be presented, as well as information about institutional
ethics consults. Copies of self-care and caregiver agreements and
educational material about advanced directives for high risk pa-
tients will be provided.
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HEALTH-RELATED QUALITY OF LIFE AND SYMPTOM DISTRESS IN
PATIENTS UNDERGOING NON-MYELOABLATIVE (NST) VERSUS MY-
ELOABLATIVE (MT) ALLOGENEIC PERIPHERAL BLOOD STEM CELL
TRANSPLANTATION (PBSCT)
Bevans, M.1, Marden, S.1, Leidy, N.2, Soeken, K.3, Rivera, P.1, Cusack,
G.1, Mayberry, H.1, Bishop, M.4, Barrett, J.5 1. National Institues of
Health, Bethesda, MD; 2. MEDTAP International, Bethesda, MD; 3.
University of Maryland, Baltimore, MD; 4. National Cancer Institute,
Bethesda, MD; 5. National Heart, Lung, and Blood Institute, Bethesda,
MD
We prospectively examined health-related quality of life
(HRQL) and symptom distress (SD) in adult patients with hema-
tologic diseases undergoing PBSCT from HLA-identical sibling
donors receiving a ﬂudarabine/cyclophosphamide (CY) regimen
NST with unmanipulated cells (n  40), or a CY-total body
irradiation regimen MT with T-cell depletion (n  36). Generic
HRQL was measured by the physical (PCS) and mental (MCS)
summary scores of the Medical Outcomes Study Short Form-36
(SF-36). The Functional Assessment of Cancer Therapy-General
(FACT-G) and Bone Marrow Transplant (FACT-BMT; FACT-
G  BMT subscale) total scores were used to measure condition-
and treatment-speciﬁc HRQL, respectively. Higher scores indicate
better HRQL. SD was measured by the Symptom Distress Scale
(SDS). Higher scores indicate a greater level of SD. Subjects
completed surveys pre-treatment (FACT-G; SF-36; SDS) and on
days 0 (FACT-BMT; SDS), 30 and 100 (FACT-BMT; SF-36;
SDS). To compare HRQL (FACT-BMT, PCS, MCS) between
MT and NST, mixed linear modeling was used taking into account
the correlation between repeated measurements within subjects
over time. Due to group baseline demographic and clinical differ-
ences, baseline PCS and FACT-G served as covariates in the
respective models. To examine the relationship between SD and
HRQL at days 30 and 100, an exploratory analysis was conducted
using multiple regression with age, gender, ethnicity, group, and
disease status also included as predictors. Subjects (N  76) were
mostly male (67%), had ECOG status 0 or 1 (97%), and were in
remission or with stable disease (65%). HRQL scores showed no
difference between groups across time and no effect for group.
HRQL improved signiﬁcantly (p  0.05) in both groups over time
with higher scores at day 100 versus days 0 and 30. At days 30 and
100, SD had the highest beta weight contributing signiﬁcantly (p
0 .001) to the variance of HRQL scores and those with lower SD
scores had higher HRQL scores (Table). For the set of predictors,
the variance explained in HRQL ranged from 43% to 72% (Ta-
ble). Results suggest NST and MT have a similar effect on HRQL
during the ﬁrst 100 days post-transplant, despite the greater inten-
sity of the MT conditioning regimen. Lower SD is associated with
better HRQL and is an important contributor to its prediction
during the ﬁrst 100 days following allogeneic PBSCT.
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UNIQUE ANTI-EMETIC MANAGEMENT IN THE PEDIATRIC BONE MAR-
ROW TRANSPLANT PATIENTS
Smith, A., Smith, C., Youssef, S., Andrews, L., Olson, E., Gonzalez-
Ryan, L. Children’s Healthcare of Atlanta, AFLAC Cancer Center,
Atlanta, GA
Bone marrow transplantation (BMT) requires a stringent prepar-
ative regimen that results in a multitude of adverse effects. One of
the most distressing effects for these patients is chemotherapy-
induced nausea and vomiting (CINV). BMT patients require close
monitoring and thorough assessments, especially when suffering a
stressful side effect. Nurses should be knowledgeable of all possible
anti-emetic therapies. Routine anti-emetics include 5-HT3 recep-
tor antagonist, dopamine receptor antagonist, benzodiazepine, an-
ti-histamine and steroid. Different combinations of the above-
mentioned medications have been used in preventing or
controlling CINV and have been effective in majority of the time.
However, there are situations that patients will suffer from persis-
tent CINV. We described a unique experience in our pediatric
BMT patients in whom a combination of diphenhydramine
(Benadryl), lorazepam (Ativan), and dexamethasone (Decadron)
(BAD) was administered (modiﬁed from Dix SP et al, Bone Mar-
row Transplant, 1999). Patients received this mixture as a contin-
uous infusion and with patient-controlled boluses for persistent
CINV control. A total of 10 patients received the BAD drip during
the BMT course. Even with the continuous infusion, the accumu-
lated daily amount of each medication patient received was actually
lower than the total dose when each medication was given at
scheduled intervals. All patients experienced improved CINV
Table. Signiﬁcant Predictors of HRQL at Days 30 and 100
FACT-BMT PCS MCS
Beta Beta Beta
Day 30
Symptom distress .74† .61† .53†
Treatment group
(1  MT; 2 
NST) .22* — —
Gender (female) — .21* .28*
R2 (adj.R2) .61 (.56) .50 (.44) .43 (.36)
Day 100
Symptom distress .76† .55† .44†
Ethnicity (white) .32* — —
Age — .44† —
R2 (adj.R2) .72 (.67) .47 (.39) .46 (.37)
*P  .05; †P  .001.
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